Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Shares Issued (2016 - 2025)

Historic Shares Issued for Evogene (EVGN) over the last 12 years, with Q2 2025 value amounting to $160000.0.

  • Evogene's Shares Issued changed N/A to $160000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year decrease of 7101.68%. This contributed to the annual value of $2.3 million for FY2024, which is 7290.8% down from last year.
  • According to the latest figures from Q2 2025, Evogene's Shares Issued is $160000.0.
  • Evogene's Shares Issued's 5-year high stood at $8.1 million during Q3 2023, with a 5-year trough of $3000.0 in Q1 2024.
  • Over the past 5 years, Evogene's median Shares Issued value was $45000.0 (recorded in 2023), while the average stood at $870153.8.
  • Data for Evogene's Shares Issued shows a peak YoY increase of 471333.33% (in 2024) and a maximum YoY decrease of 9954.14% (in 2024) over the last 5 years.
  • Over the past 5 years, Evogene's Shares Issued (Quarter) stood at $8000.0 in 2021, then skyrocketed by 162.5% to $21000.0 in 2022, then soared by 114.29% to $45000.0 in 2023, then soared by 4713.33% to $2.2 million in 2024, then crashed by 92.61% to $160000.0 in 2025.
  • Its last three reported values are $160000.0 in Q2 2025, $2.2 million for Q4 2024, and $37000.0 during Q3 2024.